Close

Sorrento Therapeutics (SRNE) Unit to Acquire Semnur Pharmaceuticals

August 16, 2016 5:49 AM EDT Send to a Friend
Scintilla Pharmaceuticals, Inc. ("Scintilla"), a subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), has entered into a binding term sheet to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login